: Frequently cited as a top pick for its leadership in the weight-loss market with Mounjaro and Zepbound . It remains the world's largest healthcare company by market cap.
For April 2026, analysts and market data highlight several top-performing and undervalued pharmaceutical stocks driven by strong pipelines in obesity, diabetes, and oncology. top pharma stocks to buy now
: Ranked as a "Best Buy" by Morningstar due to its "Wide Economic Moat" and dominance in the GLP-1 (weight loss/diabetes) sector. : Frequently cited as a top pick for